Accessibility Menu
Targeted Medical Pharma logo

Targeted Medical Pharma(OTC) TRGM

Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-100%
5 Year-100%
1 Year+600%
1 Month-93%
$0.00
+0.00%
+0.00Today
Targeted Medical Pharma last closing stock price
MetricPriceDate
Last closeUSD 0.002026-05-14
Targeted Medical Pharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+600%USD 0.002026-05-07
1 month-93%USD 0.002026-03-05
3 month+600%USD 0.002025-11-12
Year to date+600%USD 0.002025-11-12
1 year+600%USD 0.002025-02-25
3 year-93%USD 0.002023-04-12
5 year-99.99%USD 0.052021-05-11
Since inception-100%USD 5.002012-10-17

Targeted Medical Pharma Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.26M

Net Income (TTM)

-$3.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-9.00 (Low)

Price

$0.00

Volume

2,900

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Feb 26, 2025

TRGM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Targeted Medical Pharma

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing amino acid-based medications. The company operates under the brand Physician Therapeutics, providing innovative medical food products and dietary supplements primarily for various health conditions.

Products and Services
  • Patented amino acid-based medical food products
  • Dietary supplements for metabolic syndrome and sleep disorders
  • Proprietary billing process and software for physician dispensing
Growth Outlook
  • Expanding product line targets diverse health conditions
  • Strong demand for amino acid-based therapies in the healthcare market
  • Potential for increased revenue through enhanced distribution channels
Financial Highlights
  • Recent quarterly revenue of 1,288,658, showing growth potential
  • Gross profit margin of 60.2% indicates strong product profitability
  • Operating cash flow of 76,543 reflects operational efficiency
Targeted Medical Pharma, Inc. is positioned in the healthcare sector, focusing on innovative solutions for various medical conditions. The company’s product offerings include patented amino acid-based medical foods and dietary supplements, which cater to a growing market for specialized health solutions. The proprietary billing process and software enhance the efficiency of physician dispensing, further solidifying the company's role in the healthcare ecosystem. The growth outlook for Targeted Medical Pharma is promising, driven by an expanding product line that addresses a range of health issues, including metabolic syndrome and sleep disorders. The increasing demand for amino acid-based therapies presents significant opportunities for revenue growth, particularly as the company enhances its distribution channels. Financially, the company has demonstrated a recent quarterly revenue of 1,288,658, indicating a positive trajectory. The gross profit margin of 60.2% highlights the profitability of its products, while an operating cash flow of 76,543 suggests operational efficiency. These financial metrics reflect the potential for sustained growth and profitability in the future.
AI Generated • Aug 3, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Los Angeles, CA 90077, US

TRGM Financials

Key Financial Metrics (TTM)

Gross Margin

60.17%

Operating Margin

-38.58%

Net Income Margin

-57.86%

Return on Equity

26.62%

Return on Capital

N/A

Return on Assets

-125.41%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

30.19M

Volume

2.90K

Avg. Volume

46.032

Financials (TTM)

Gross Profit

$3.17M

Operating Income

-$2.03M

EBITDA

-$1.66M

Operating Cash Flow

-$1.28M

Capital Expenditure

-$4.00K

Free Cash Flow

-$1.28M

Cash & ST Invst.

$82.64K

Total Debt

$5.29M

Targeted Medical Pharma Performance Analysis

Targeted Medical Pharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12015-03-31-24.6%
Q22015-06-3025.7%
Q32015-09-3016.4%
Q42015-12-31-17.5%
Targeted Medical Pharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12015-03-31-7.5%
Q22015-06-3066.7%
Q32015-09-3050.0%
Q42015-12-31-114.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2015YOY CHG

Revenue

$1.29M

-9.0%

Gross Profit

$775.83K

+1.4%

Gross Margin

60.20%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.67

N/A

Employees

30

N/A

Net Income

-$581.47K

+60.8%

EBITDA

-$313.31K

+69.2%

Quarterly Fundamentals

Name
Q4 2015YOY CHG

Total Cash

$82.64K

+604.0%

Total Debt

$5.29M

+42.4%

Accounts Receivable

$467.50K

+91.8%

Inventory

$92.19K

-27.5%

Long Term Debt

$670.90K

+448.6%

Short Term Debt

$4.62M

+28.5%

Return on Assets

-1.25%

N/A

Return on Invested Capital

16.57%

N/A

Free Cash Flow

$76.54K

-67.8%

Operating Cash Flow

$76.54K

-67.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBIMGlobeImmune, Inc.
$0.00+0.00%
NLVVFNew Leaf Ventures Inc
$0.00+0.00%
SYVCSynovics Pharmaceuticals, Inc.
$0.00+0.00%
CMRAComera Life Sciences Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About TRGM

What is the current price of Targeted Medical Pharma?

Targeted Medical Pharma is trading at $0.00 per share.

What is the 52-week range for Targeted Medical Pharma?

Over the past 52 weeks, Targeted Medical Pharma has traded between $0.00 and $0.02.

How much debt does Targeted Medical Pharma have?

Targeted Medical Pharma total debt is unavailable.

How much cash does Targeted Medical Pharma have on hand?

Targeted Medical Pharma does not have cash on hand data available.

What is Targeted Medical Pharma’s dividend yield?

Targeted Medical Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services